Sort
64,565 grants matching “drug discovery”
Regulation of resistance to CDK4/6 inhibitor in breast cancer
$633,959Wenge Zhu · George Washington University · R01 · FY2025 · CA
The multiple antibiotic resistance (Mar) regulon
$633,945Stuart B. Levy · Tufts University Boston · R01 · FY2012 · AI
Research Core
$633,838W Kelley Thomas · University Of New Hampshire · P20 · FY2017 · GM
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$633,787Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Mechanisms of FGF Receptor Regulation and Signaling
$633,765Moosa Mohammadi · New York University School Of Medicine · R01 · FY2011 · DE
New Quantitative Neuroimaging Metrics of Structural and Functional Connectivity of the Locus Coeruleus as a Novel Biomarker of Alzheimer's Disease Pathogenesis and Progression
$633,753Lawrence R. Frank · University Of California, San Diego · R01 · FY2019 · AG
The molecular genetic analysis of human obesity
$633,735Rudolph L Leibel · Columbia University Health Sciences · R01 · FY2018 · DK
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
$633,691Peter Alexander Ljubenkov · University Of California, San Francisco · R01 · FY2024 · AG
Immunology Team Contributions to the LSB
$633,676Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Rational Design of Antibiotics Targeted at the Ribosome
$633,600Anadys Pharmaceuticals, Inc. · R44 · FY2005 · AI
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$633,596Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$633,557Louise Sumner · Gryphon Scientific, Llc · N01 · FY2020 · AI
Does neurotransmitter plasticity of para-serotonergic neurons augment autoresuscitation following perinatal stress and buffer SIDS risk?
$633,400Susan M Dymecki · Harvard Medical School · R01 · FY2024 · HD
Machine learning drives translational research from drug interactions to pharmacogenetics
$633,396Lang Li · Ohio State University · R01 · FY2023 · LM
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
$633,328Christopher Keith Haddock · Ndri-Usa, Inc. · R01 · FY2025 · DA
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
$633,319Todd D Gould · University Of Maryland Baltimore · R01 · FY2022 · MH
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
$633,309Balabhaskar Prabhakarpandian · Cfd Research Corporation · R44 · FY2012 · CA
Alzhelmer's Disease Drug Development Program
$633,176Amos B Smith · University Of Pennsylvania · U01 · FY2008 · AG
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$633,171John J Mekalanos · Harvard Medical School · R01 · FY2009 · AI
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
$633,135Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DA
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
$633,135Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DA
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
$633,135Xiang-Qun Xie · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · DA
Developing Autophagy-Targeting Chimeras and Optimizing Cell Penetration of Large-Molecule Therapeutics
$633,124Joshua A Kritzer · Tufts University Medford · R35 · FY2024 · GM
Interference with Androgen Receptor and Its Ligands
$633,005James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2010 · CA
Medicinal Chemistry
$633,001Craig Lindsley · Vanderbilt University · U01 · FY2014 · MH